|
|
|
Volumn 84, Issue 3, 1997, Pages 188-193
|
|
Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
COLORING AGENT;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ARTICLE;
BIOPSY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MELANOMA;
METASTASIS;
NEOPLASM;
NUCLEAR MEDICINE;
PATHOLOGY;
PATIENT CARE;
PEROPERATIVE CARE;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SCINTILLATION CAMERA;
SCINTISCANNING;
SKIN TUMOR;
SURGERY;
SURVIVAL RATE;
ANTINEOPLASTIC AGENTS;
BIOPSY;
COLORING AGENTS;
COST-BENEFIT ANALYSIS;
GAMMA CAMERAS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INTERFERON ALFA-2B;
INTRAOPERATIVE CARE;
LYMPH NODE EXCISION;
LYMPH NODES;
LYMPHATIC METASTASIS;
MELANOMA;
NEOPLASM STAGING;
NEOPLASMS, UNKNOWN PRIMARY;
NUCLEAR MEDICINE;
PATHOLOGY;
PATIENT CARE TEAM;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDIES;
RADIOPHARMACEUTICALS;
RANDOMIZED CONTROLLED TRIALS;
SKIN NEOPLASMS;
SURGERY;
SURVIVAL RATE;
|
|
EID: 0031089048
PISSN: 00154148
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (25)
|
|
References (0)
|
